Roivant Sciences ROIV
NASDAQ ROIV
$34.94 +0.53 (+1.54%)
As of: Sep 4, 2026 · 3:59 PM EDT

Roivant Sciences (ROIV) Asset Utilization Ratio (2021 - 2026)

Roivant Sciences' (ROIV) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2025, down 37.35% YoY from 0.01 in Q4 2024, and up 2.31% on a QoQ basis from 0.01 in Q3 2025.

Analysis

Roivant Sciences (ROIV) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Roivant Sciences (ROIV) has 5 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2025.

  • Quarterly Asset Utilization Ratio fell 37.35% year-over-year to 0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01 (down 37.35% YoY) and the FY2026 annual result came in at 0.0, down 70.8% from the prior year.
  • Asset Utilization Ratio advanced to 0.01 in Q4 2025, from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.04 in Q4 2022 to a low of 0.01 in Q3 2025.
  • A 5-year average of 0.02 and a median of 0.01 in 2021 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2022 — Asset Utilization Ratio surged 328.11% — and 2024, when it tumbled 81.64%.
  • Tracing ROIV's Asset Utilization Ratio over 5 years: stood at 0.02 in 2021, then soared by 75.88% to 0.04 in 2022, then tumbled by 59.67% to 0.02 in 2023, then sank by 45.63% to 0.01 in 2024, then plunged by 37.35% to 0.01 in 2025.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.38
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.20
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.69
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 0.90
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.13
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.54
10 Roivant Sciences 25.18 Bn 25.18 Bn 1.16 Mn 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Dec 31, 2023 0.02
Sep 30, 2023 0.03
Jun 30, 2023 0.03
Dec 31, 2022 0.04
Sep 30, 2022 0.03
Jun 30, 2022 0.03
Dec 31, 2021 0.02
Sep 30, 2021 0.01
Jun 30, 2021 0.01